Listed

Orthofix Medical Inc.

OFIXNasdaqCIK 884624HealthcareFiscal year ends Dec 23

Reports and events: 368 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Orthofix Medical Inc., Reports and events
FiledFormWhat it isAccession number
2024-01-0816:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-24-002924
2023-12-1516:14 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-070740
2023-12-1317:16 ETSC 13D/AOwnership report, active investor, amended0000921895-23-002760
2023-12-0116:31 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-23-067364
2023-11-0816:15 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-061148
2023-11-0816:12 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-23-061122
2023-11-0816:09 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0000950170-23-061099
2023-11-0317:15 ETSC 13DOwnership report, active investor0000921895-23-002456
2023-10-0519:21 ET8-K5.02 Departure or appointment of officers or directors0000950170-23-052018
2023-10-0317:21 ET8-K5.02 Departure or appointment of officers or directors0000950170-23-051671
2023-09-1421:56 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-234766
2023-08-0816:28 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-039884
2023-08-0816:24 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-23-039871
2023-06-2107:01 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000950170-23-029063
2023-06-2016:02 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-028907
2023-06-1516:58 ET8-K9.01 Financial statements and exhibits0000950170-23-028350
2023-05-0916:21 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-019721
2023-05-0916:16 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-23-019696
2023-04-2717:06 ETDEF 14AProxy statement0000950170-23-015379
2023-04-0717:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000950170-23-012209
2023-03-1307:29 ET8-K7.01 Regulation FD disclosure0000950170-23-007437
2023-03-0616:11 ET10-KAnnual reportPeriod 2022-12-310000950170-23-006242
2023-03-0616:09 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-23-006239
2023-02-1319:03 ET8-K/A9.01 Financial statements and exhibits0000950170-23-002508
2023-01-0907:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-000431
2023-01-0506:08 ET8-K1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-001900
2023-01-0416:31 ET8-K5.07 Shareholder vote results0001193125-23-001527
2022-12-2717:26 ET8-K8.01 Other events0001193125-22-312734
2022-12-0517:24 ET8-K8.01 Other events0001193125-22-298551
2022-11-3017:25 ET8-K8.01 Other events0001193125-22-295519
2022-11-2121:51 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-289289
2022-11-0307:13 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-021538
2022-11-0307:08 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-22-021534
2022-10-1106:37 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-260160
2022-10-1106:29 ET8-K1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-260149
2022-08-0507:34 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-014951
2022-08-0507:09 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-22-014943
2022-06-0707:36 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000950170-22-011247
2022-05-0607:58 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-007997
2022-05-0607:57 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-22-007996
2022-04-2716:30 ETDEF 14AProxy statementPeriod 2022-06-060001564590-22-016085
2022-04-0807:19 ET8-K5.02 Departure or appointment of officers or directors0000950170-22-005488
2022-02-2508:21 ET10-KAnnual reportPeriod 2021-12-310001564590-22-006929
2022-02-2508:15 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-22-006928
2022-01-1007:30 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-22-000766
2021-12-1407:30 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-060217
2021-11-0508:21 ET10-QQuarterly reportPeriod 2021-09-300001564590-21-054754
2021-11-0508:15 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-054753
2021-09-2907:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-049312
2021-09-2308:00 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-048661

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 17:00 ET. Listed shows no prices and gives no investment advice.